Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register

Supplying Medicines and Supplements to Malaysia

A practical guide for Malaysian importers, distributors and brand owners who source from abroad, and for manufacturers and exporters worldwide selling into Malaysia.

Malaysia has a mature regulator with clear, published timelines. For manufacturers outside the PIC/S scheme, the step that needs the most planning is GMP: their plants, including those in India, usually need an inspection by NPRA, Malaysia's regulator.

Supplements are a strong market too. In our search data, magnesium glycinate is the most searched supplement in Malaysia, and many buyers ask for halal certification.

Malaysia at a glance

RegulatorNational Pharmaceutical Regulatory Agency (NPRA), with the Drug Control Authority (DCA) deciding on registration
Who holds the registrationA locally incorporated company registered with the Companies Commission of Malaysia (SSM)
Timelines210 working days for prescription generics, 116 to 136 for non-prescription generics on the abridged route, and 100 to 120 for health supplements
Plants outside PIC/SUsually need an NPRA foreign GMP inspection, paid for by the applicant. India, for example, is not a PIC/S member
Fast routeFacilitated registration for products approved by the FDA, EMA and other reference regulators: 90 working days for abridged review, 30 for verification

How to supply medicines to Malaysia

  1. Appoint a local registration holder. A Malaysian company registered with SSM, with a health or pharmaceutical business scope, holds the registration and the import licence.
  2. Plan the GMP inspection. NPRA normally accepts GMP certificates from PIC/S members and ASEAN partners. For a plant outside PIC/S, such as one in India, plan for an NPRA inspection, with fees from about RM25,000 plus travel costs. Keep your GMP evidence current.
  3. Register the product. An ACTD dossier, with documents and labels in English or Bahasa Malaysia. Registrations last five years, and packs carry the approved security hologram.
  4. Supply. Private pharmacies, clinics and hospitals, or the Ministry of Health, which buys through a supply concession and asks for at least two suppliers for off-patent medicines.

Under regulation 15(6) of the Control of Drugs and Cosmetics Regulations 1984, the Director of Pharmaceutical Services can allow an unregistered medicine to be imported to treat a patient with a life-threatening illness. See named-patient and special import and government tender supply.

Supplements

Health supplements are registered with NPRA, usually in 100 to 120 working days, and the manufacturer needs GMP. Any halal logo on the pack must come from JAKIM or a body JAKIM recognises. We help brands get supplements made under their own label by GMP-certified contract manufacturers: see nutraceutical private label.

What people in Malaysia search for

Semrush data from October 2026 shows that people in Malaysia search most for magnesium glycinate (about 27,100 searches a month), vitamins C and D, magnesium, probiotics, vitamin B12, creatine and ashwagandha.

Supplements we can help you make

Among medicines, the most searched generic names include ivermectin, amlodipine, atorvastatin, cetirizine, celecoxib and pantoprazole.

Documents to ask your supplier for

Not sure a supplier is genuine? Read how to verify a pharmaceutical supplier. For the neighbouring markets, see our Southeast Asia (ASEAN) import guide.

Sourcing for Malaysia?

Send the product, strength, quantity and the documents your regulator needs. We will match you with GMP-certified manufacturers and suppliers who can serve your market, wherever they are based.

Send your requirement Talk to our team

Frequently asked questions

The National Pharmaceutical Regulatory Agency (NPRA), under the Ministry of Health. The Drug Control Authority (DCA) makes the registration decisions.

No. The registration holder must be a locally incorporated company registered with the Companies Commission of Malaysia (SSM).

Plants with GMP certificates from PIC/S members or ASEAN partners usually don't. Plants elsewhere, including in India, which is not a PIC/S member, are usually inspected, with the costs paid by the applicant.

NPRA's targets are 210 working days for prescription generics, 116 to 136 for non-prescription generics on the abridged route, and 245 for new medicines and biologics.

Yes, in limited cases. Under regulation 15(6), the Director of Pharmaceutical Services can allow one to be imported to treat a patient with a life-threatening illness.

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us